SAM #36E79727R0001

VA procurement for annual supplies of 300 mcg and 480 mcg filgrastim or biosimilar syringes

The Department of Veterans Affairs is seeking filgrastim syringes or biosimilars for participating federal healthcare users. - Government buyer: Department of Veterans Affairs (VA), Enterprise Procurement Office, OPAL/National Acquisition Center; buyer contact: Dov Vysnia. Intended users include VA, DoD, BOP, IHS, and FHCC. - OEMs and vendors: No manufacturers or vendors are named in the notice or attachment. The procurement requests filgrastim or a biosimilar. - Products and estimated annual quantities: - 22,665 non-safety 300 mcg syringes, or biosimilar; one syringe per package. - 29,170 non-safety 480 mcg syringes, or biosimilar; one syringe per package. - Requirements: Syringes must be labeled for patient or caregiver use. Offerors must identify the exact product name and provide a unique NDC. One contract is planned to support uninterrupted supply. - Period of performance: One base year with four pre-priced one-year options. - Potential competing manufacturers and products: Amgen (Neupogen), Sandoz (Zarxio), and Pfizer (Nivestym). These companies and products are potential alternatives, not named offerors.

Description

Please see attached documents. 

View original listing